NIH-funded research Sbir 2 grant

CerviGuard: a simple blood-free screen for pregnancy risks in early pregnancy

Official title: Assay development for the assessment of pregnancy risks in early pregnancy

Funded at Akna Health LLC · NIH-11418895 · Data updated 2026-11-12

A new noninvasive cervical-fluid test called CerviGuard aims to identify pregnancy risks in the first trimester so clinicians can better manage conditions like fetal growth issues and preeclampsia.

More Pregnancy research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionAkna Health LLC
NIH-funded
Lab location1 site (Grand Rapids, United States)
Project startAugust 18, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$1,318,850
NIH project number5R44EB033715-03
Project IDNIH-11418895 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant individuals in the first trimester who are seeking prenatal screening.

Less likely to help

Tests may not improve outcomes for pregnancies without these specific risk signals or in settings where the test cannot be implemented.

What this research studies

This project uses a noninvasive cervical-fluid test collected in an office visit (like a Pap smear) to look for trophoblast-related biomarkers in early pregnancy. It combines a biomarker panel with machine learning to predict adverse pregnancy outcomes and guides how patients are monitored or treated. The study plans to validate the panel with 100 learning participants and 500 in the broader validation, while developing antibodies to improve test reliability and exploring flow cytometry adaptation for wider lab use.

Why it matters

Potential benefit: If successful, CerviGuard could provide earlier and more accurate risk stratification in pregnancy, enabling timely care to reduce complications.

How similar studies have gone: Previous pilots have shown promise, and this project aims to validate a refined biomarker panel in a larger cohort.

Where this research is happening

  • Akna Health LLC
    Grand Rapids, United States
    Active

Researchers

  • Principal investigator: Drewlo, Sascha — Akna Health LLC
  • Study coordinator: Drewlo, Sascha

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.